Drugs / FlōGraft®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03379324 | Mar 2017 → Sep 2019 | muscular atrophy, rotator cuff syndrome | Applied Biologics, LLC | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FlōGraft | “4cc of FlōGraft® injected into repair subject tissue divided evenly between repair site and muscle body” NCT03379324 ↗ |
| Modality | Other / unclassified | “human amniotic fluid derived allograft” NCT03379324 ↗ |
| Route | Other | “inject FlōGraft® directly into rotator cuff tissue at repair site” NCT03379324 ↗ |